NEC OncoImmunity AS
Vegard Børve Sørdal is a Senior Data Scientist at NEC OncoImmunity AS since September 2023. Prior experience includes serving as a Machine Learning Researcher at Forsvarets forskningsinstitutt - FFI from June 2020 to August 2023, and holding positions as a Teaching Assistant and a PhD candidate in Statistical Physics at the University of Oslo from August 2015 to September 2019. Vegard also worked as a Guest Researcher at the University of Barcelona from June 2016 to February 2017, a Summer Intern at NanoTecCenter Weiz Forschungsgesellschaft mbH in July 2013, and a Research and Teaching Assistant at the University of Hawaii at Manoa from January 2013 to June 2013, as well as a Research Assistant at The University of Tokyo from April 2012 to September 2012. Vegard holds a Ph.D. in Statistical Physics from the University of Oslo (2015-2019), an M.Sc. in Statistical Physics from the University of Oslo (2013-2015), and a B.Sc. in Physics from the University of Bergen (2008-2011).
NEC OncoImmunity AS
NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning software, which addresses the key gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines. We are dedicated to developing scalable software solutions that facilitate effective patient selection for cancer immunotherapy, and identifying optimal neoantigen targets for truly personalized cancer vaccines & cell therapies in a clinically actionable time frame. Our growing international team (13 countries and counting!) consists of a diverse mix of data scientists, bioinformaticians, immunologists, cancer researchers, and software developers. NEC OncoImmunity AS is a subsidiary of the NEC Corporation, and is based in the Oslo Cancer Cluster buildings in Oslo, Norway.